MAPT and Alzheimer disease: Giving that AD-type pathology begins 15–20 years before the onset of dementia in sporadic AD33, the elevated Aβ and P-tau levels observed in our patients suggest that OSAS may contribute to the initiation of AD pathogenesis in young patients.